Status:
COMPLETED
A Study to Evaluate Ezetimibe in Korean Patients With Primary Hypercholesterolemia (0653-042)
Lead Sponsor:
Organon and Co
Conditions:
Hypercholerolemia
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Patients undergo 4-week placebo lead-in and diet period, and 12-week treatment period. Clinical efficacy and safety is evaluated at weeks 4, 8 and 12. This study takes approximately 18 weeks for an in...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Korean males or females at least 18 years of age with hypercholesterolemia
Exclusion
Key Trial Info
Start Date :
December 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2003
Estimated Enrollment :
136 Patients enrolled
Trial Details
Trial ID
NCT00157911
Start Date
December 1 2002
End Date
December 1 2003
Last Update
August 15 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.